Issuer Flash: China Modern Dairy Holdings Ltd.

Report date: 2026-07-27 Event date: 2026-03-24 Event title: FY2025 Final Results

1. Flash Conclusion

China Modern Dairy's FY2025 final results show that operating cash generation remained resilient through a weak raw-milk market, but they do not remove the balance-sheet pressure created by falling biological-asset values, higher finance costs and refinancing needs. Revenue fell 4.9% to RMB12.601bn, while Cash EBITDA increased 2.6% to RMB3.063bn and operating cash flow increased 4.1% to RMB2.502bn. The company achieved this by raising raw-milk volume and reducing feed and unit production costs, despite a lower selling price.

For bondholders, the more important counterweight is that fair-value losses on dairy cows rose to RMB3.108bn, producing a RMB1.204bn loss for the year and reducing total equity to RMB9.818bn. The results therefore support the existing view that Modern Dairy has meaningful operational defences through scale, cost control and its Mengniu-linked sales base, but remains exposed to the raw-milk price cycle and to a weaker equity and leverage profile. The disclosure does not provide a basis to assume that liquidity is fully insulated from a further price decline or that Mengniu provides a legal guarantee for the issuer's U.S.-dollar bonds. In particular, year-end cash and facilities need to be viewed against a sizeable current-debt stack rather than as a standalone liquidity surplus.

2. FY2025 Results: Cash Earnings Held Up While Asset Values Fell

Raw-milk sales volume rose 8.5% to 3.139m tonnes, while average milk yield was broadly stable at 12.9 tonnes per head per year. These improvements partly offset the 7.7% decline in raw-milk ASP to RMB3,335 per tonne. Raw-milk unit cost fell to RMB2.32/kg from RMB2.53/kg, with average feed cost down to RMB1.77/kg from RMB1.95/kg. This combination preserved gross profit, but it should be read as cost and volume absorption of a price shock rather than recovery in pricing power.

The fair-value loss on dairy cows was larger than Cash EBITDA. Although it is not equivalent to an immediate cash outflow, it matters to creditors because repeated write-downs reduce equity, increase gearing and can weaken the collateral and refinancing narrative over time. The distinction between positive operating cash flow and declining biological-asset values is therefore central to the FY2025 credit read-through.

3. Credit Read-Through for Bondholders

Liquidity indicators in the final-results announcement are supportive but not conclusive. At year-end, the group reported cash and bank balances of approximately RMB7.91bn and undrawn credit facilities of RMB7.420bn, of which RMB2.386bn expired after more than one year. These resources, together with expected operating cash inflow, supported the directors' going-concern assessment despite net current liabilities of RMB467m. The disclosed current funding burden was nevertheless material: current bank borrowings were RMB2.189bn, other borrowings RMB1.643bn, long-term bonds due within one year RMB3.100bn and short-term debenture RMB204m. Together these interest-bearing items totalled about RMB7.136bn before current lease liabilities of RMB209m.

The comparison is constructive in that reported cash and bank balances broadly covered the stated current interest-bearing debt at year-end, before considering operating cash flow and facilities. It is not, however, a complete maturity analysis. Cash includes balances reported as non-current, the announcement does not provide the committed/uncommitted split of facilities, and only about one-third of the RMB7.420bn undrawn amount was stated to expire after more than one year. The company also identified RMB1.000bn of the facilities as coming from Inner Mongolia Mengniu, a Mengniu subsidiary; this is a source of relationship-based funding support, not disclosed legal support for the offshore notes. Finance costs increased 20.5% to RMB637m, while net gearing rose to 115.7% from 97.1%. Accordingly, the relevant credit question is less whether year-end liquidity covered near-term debt on a snapshot basis, and more whether cash generation and bank refinancing can be maintained if raw-milk pricing or biological-asset values weaken again.

The availability, committed nature, tenor and conditions of facilities therefore remain more relevant than the headline undrawn amount alone. The final-results announcement reports the directors' assessment that the group can meet obligations as they fall due, but it does not disclose sufficient facility detail to treat all reported headroom as equally dependable under a stressed refinancing scenario. A bondholder should also distinguish the group-level liquidity disclosure from the structural position of the Cayman holding-company issuer.

The results also show why it would be premature to treat the improvement in accounting loss as deleveraging. Loss for the year narrowed from RMB1.469bn to RMB1.204bn, but the decline in total equity and increase in net gearing moved in the opposite direction to Cash EBITDA. The FY2025 outcome is consequently best viewed as a year in which the company defended operating cash generation while the balance sheet remained vulnerable to another prolonged period of weak raw-milk economics. That distinction is particularly relevant when assessing refinancing capacity over more than the next reporting period.

For the U.S.$350m 4.875% Sustainability Bonds due 2030, retained cash generation, reported cash balances and undrawn facilities are positive supports, but the issuer is a Cayman holding company. The final-results disclosure does not change the need to distinguish operating support from legal creditor protection: Mengniu's ownership and customer relationship support sales stability, but neither this disclosure nor the existing source set confirms a Mengniu guarantee of the bonds. A further raw-milk price decline could pressure cash earnings first through margins and then through working capital or refinancing terms, while continued biological-asset losses would add pressure through equity and gearing.

The current 2026-05-15 issuer summary contains broader analysis of the Shengmu transaction and bond documentation. Those later matters are not treated as facts in this event-driven flash. They remain separate items for primary-source confirmation rather than evidence that FY2025 results have already resolved the group's funding or integration risk.

4. What To Watch Next

• Raw-milk ASP, volume, feed costs and unit production cost in the FY2026 interim disclosure. A repeat of volume growth without pricing recovery would test the durability of Cash EBITDA and operating cash flow.
• The scale of any further dairy-cow fair-value loss, the movement in equity and net gearing, and whether the balance sheet begins to stabilise rather than merely absorb another annual revaluation.
• Cash balances, short-term debt, the portion of facilities available beyond one year and the terms of the Mengniu-related facility. The final-results announcement does not disclose sufficient detail to treat all undrawn facilities as equally dependable under stress.
• The relationship between operating cash flow and the refinancing burden. The FY2025 cash balance broadly matched current interest-bearing debt at year-end, but a sustained cash-flow buffer also depends on the rollover of facilities and the absence of renewed pressure on asset values or working capital.
• Primary-source updates on current ratings, the 2030 bond's market levels, and any post-results Shengmu funding or completion developments. These items were not confirmed by the FY2025 results announcement and should not be inferred.

5. Sources

• China Modern Dairy Holdings Ltd., Announcement of Final Results for the year ended 31 December 2025, 24 March 2026, HKEX: https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0324/2026032401698.pdf. Used for FY2025 financial, operating, liquidity and borrowing information.